Delivery Order SPE2DB20D1047-SPE2DB25FF43S

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,365.99 firm fixed-price delivery order is for the supply of 40,000 unit capsules of the drug ZENPEP. The contract has an ultimate completion date of December 12, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award from the Defense Logistics Agency (DLA) is a Firm Fixed Price Delivery Order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,697.70 contract is for the supply of 40,000-unit capsules of the drug ZENPEP DR, with an ultimate completion date of November 21, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,383.30 firm fixed-price contract is for the delivery of 60,000 units of the pharmaceutical drug ZENPEP DR 100S, with a period of performance through February 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,182.72 Firm Fixed Price Delivery Order contract is for the supply of 20,000-unit capsules of the drug ZENPEP DR. The contract has an ultimate completion date of February 21, 2025 and was awarded on February 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,912.66, is for the delivery of Zenpep, a drug capsule, with a completion date of May 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 4,561,437,257 ZENPEP DR 20,000 unit capsules. The firm-fixed-price contract, valued at $1,637.27, has a completion date of July 10, 2023. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distributor Amerisourcebergen Corporation. The order, valued at $8,319.47, is for the delivery of 40,000 unit capsules of the prescription drug ZENPEP. This award does not have a set-aside designation. The delivery order falls under Amerisourcebergen Drug Corp's larger indefinite delivery contract with DLA...
This federal contract award, valued at $27,032.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ZENPEP DR 40,000 UNIT CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and is a Firm Fixed Price contract. No set-aside designation was used for this award. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a prominent pharmaceutical distribution company, for the supply of 40,000-unit capsules of the drug Zenpep. The award has a ceiling value of $6,846.77 and a completion date of September 10, 2024. The contract is a firm-fixed-price delivery order, which means the price is set and not subject to adjustment. AmerisourceBergen, through its Corporate Office division, has been awarded this...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,127.68 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of 4,564,242,620 ZENPEP DR 15,000 UNIT CAPSULES 100S, a pharmaceutical product, with a performance period through April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB25FF43S
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 20,000 unit capsules of the drug ZENPEP DR 100S. The $2,972.08 firm fixed-price contract has a completion date of February 20, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 5/21/25, 10:12 AM